ϩ concentration is reported for humans, only 5-10 milliequivalents per liter (meq/l) (28, 29, 47) , compared with 136 -145 meq/l in plasma (47) . Cl Ϫ , PO 4 3Ϫ , and glucose concentrations in milk are reported to have a positive correlation with Na ϩ concentration, whereas lactose and Ca 2ϩ concentrations have negative correlations (29) . However, the mechanisms that control ion transport across mammary epithelium and contribute the low Na ϩ concentration in milk across all species and explicitly the very low Na ϩ concentration in human milk are not fully understood. Recent reports describe murine (1, 3, 6) and bovine (35, 36, 44 ) mammary epithelial models to study active ion transport, especially Na ϩ transport via the epithelial Na ϩ channel (ENaC) in the apical membrane. It has been reported that three ENaC subunits, ␣, ␤, and ␥, are present in human and mouse mammary gland epithelium (3) . Steroid hormones were reported to enhance ENaC expression in human, mouse, and bovine mammary epithelia, which could account for Na ϩ movement during lactation and oncogenesis (3, 36) . Previous reports from this laboratory detail results from a bovine mammary cell line, BME-UV cells, that developed an electrically tight monolayer when cultured on permeable supports. Amiloride-sensitive I sc was induced by natural and synthetic corticosteroids (35, 36, 44) . Moreover, results from this bovine mammary epithelial model suggest that luminal Na ϩ concentration is an important regulator for tight junction integrity (35) . Typically, a leaky epithelial barrier is observed in vivo before parturition (30) . At the onset of lactation, however, the epithelial layer lining the mammary gland becomes relatively impermeable to small solutes such as monovalent ions, sugars, and small carbohydrates and substantial concentration gradients for these solutes are generated (30) . If the mammary gland develops mastitis, however, the mammary epithelial barrier becomes leaky. Increased Na ϩ and Cl Ϫ concentrations are reported in mastitic milk, and increased milk electrical conductivity, indicating elevated electrolyte levels, has been used as a preclinical sign of mastitis (10, 21) . There is an ongoing question, however, whether mastitis compromises the epithelial barrier to induce an increase in milk electrolytes via mixing with interstitial fluids or whether mastitis induces a decrease in Na ϩ absorption and a resultant increase in milk electrolyte concentration, which then causes the epithelia barrier to break down (17, 35, 44) .
MCF10A cells, which were derived from nonneoplastic human mammary tissue (54) , have been used to study mammary function and regulation (3) . In one case, it was reported that MCF10A cells failed to form tight junctions (8) . In contrast, another study showed that MCF10A cells not only formed tight junctions but that an electrically tight monolayer developed that could be used to assess ion transport and responses to agonists (58) . In examining these reports further, it was determined that one distinct difference in the culturing systems was the presence or absence of cholera toxin (Ctx) in the growth medium. The use of Ctx in mammary cell culture can be traced back to 1979 (60) . Ctx is widely known to interact with intestinal epithelial cells to increase cytosolic cAMP and ultimately to increase anion secretion (45, 46) . Evidence suggests that Ctx also increases cAMP generation in mammary epithelia (33) . However, there is no extant report indicating that Ctx has direct effects on ion transport across mammary epithelium and only occasionally has it been suggested that Ctx might have direct effects on epithelial barrier integrity or on cation transport (27, 33, 54) . One study reported that Ctx increased cAMP in MCF10A cells, which affected acini lumen formation in a three-dimensional culture system (27) . This result suggests an increase in anion secretion. Whether there was a Ctx-induced change in either barrier integrity, anion, or cation transport, however, was not determined.
In the present study, MCF10A cells were cultured in the presence or absence of Ctx, initially, to determine its effect on barrier formation. Regardless of whether Ctx was present, electrically tight epithelial monolayers were observed and acute changes in net ion transport could be induced. Surprisingly, the results from initial experiments suggested that Ctx might promote enhanced levels of Na ϩ absorption. Thus the primary goals for this study were to describe the effects of Ctx on Na ϩ absorption across cultured mammary epithelial cells. The outcomes suggest that Ctx builds on corticosteroid-induced ENaC expression to enhance the rate of Na ϩ absorption by increasing the amount of ENaC that is resident in the apical membrane.
MATERIALS AND METHODS
Cell culture. The MCF10A cell line, which was derived from nonneoplastic human mammary tissue, was obtained from Dr. Nelson Horseman (University of Cincinnati, Cincinnati, OH) and used throughout this study. Unless indicated otherwise, chemicals were obtained from Sigma-Aldrich (St. Louis, MO). Two media were used for cell culture. Typical medium contained DMEM/F-12 (Cellgro, Herndon, VA), horse serum (5%; GIBCO, Grand Island, NY), insulintransferrin-Na ϩ selenite (10 g/ml), penicillin and streptomycin (1%; GIBCO), L-glutamine (2 mM), hydrocortisone (cortisol, 0.5 g/ml), and epidermal growth factor (20 ng/ml; R&D Systems, Minneapolis, MN). Ctx medium contained typical medium with 100 ng/ml Ctx. Continuous cultures of MCF10A cells were maintained on solid supports (25-cm 2 plastic culture flasks; Corning, Lowell, MA) using typical medium. After reaching 80 -90% confluence, cells were detached using trypsin in phosphate-buffered saline (PBS) with disodium EDTA (2.4 mM; GIBCO) for 7-10 min, suspended in culture medium, and seeded on permeable supports (Snapwell or Transwell; 1.13 or 4.67 cm 2 , respectively; Corning). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO2. Media were refreshed every day until experimentation, which typically was 14 days postseeding. In some experiments, MCF10A cells were also cultured in treatment media, such as LY294002 (50 M), H-89 (10 M), brefeldin A (10 g/ml), isoproterenol (100 nM), or Rp-cAMP (100 M) in typical or Ctx medium, or Ctx B subunit (67 ng/ml) in typical medium. The duration of treatment exposure indicates the last hours or days before the experiment during which treatment exposure occurred. For example, when cells were exposed in Ctx for 4 days or 7 days, cells were cultured in medium containing Ctx on days 11-14 or 8 -14, respectively. All cell culture-based treatments were administered symetrically in the mucosal and serosal chambers.
Electrical measurements. A modified Ussing-style system was used to measure active net transepithelial ion transport and electrical resistance as described in detail previously (35, 36, 44) . Briefly, the cultured monolayer on its permeable support was inserted to separate the two halves of an acrylic chamber (DCV9; Navicyte, San Diego, CA). The mucosal and serosal hemichambers were filled with equal volumes of Ringer solution (composition in mM; 120 NaCl, 25 NaHCO3, 3.33 KH2PO4, 0.83 K2HPO4, 1.2 CaCl2, and 1.2 MgCl2). Each hemichamber was mixed continually by an airlift system (5% CO2-95% O2) that also maintained a stable pH (7.4). The system was maintained at 37°C. Custom-made voltage-sensing and current-injecting electrodes were placed in each chamber and connected to a voltage clamp (model 558C; University of Iowa, Department of Bioengineering, Iowa City, IA) to determine open circuit voltage, to clamp the voltage and to measure short circuit current (I sc). Monolayers were clamped to 0 mV with the exception of an intermittent 1-mV bipolar pulse to allow for the determination of transepithelial electrical resistance (R te). Voltage and current measurements were acquired digitally at 1 Hz (MP100A-CE interface and Aqknowledge software, ver. 3.2.6; BIOPAC Systems, Santa Barbara, CA) throughout all experiments. Ion transport modulators were added as 1,000ϫ stock solutions to achieve the reported working concentrations either to the mucosal hemichamber (amiloride), to the serosal hemichamber (bumentanide), or symmetrically (forskolin, Calbiochem, Gibbstown, NJ; glibenclamide).
Semiquantitative RT-PCR. To determine the relative copy numbers of mRNA coding for ␣-, ␤-, and ␥-ENaC, RNA was isolated from MCF10A monolayers after Ussing chamber experiments were completed by using Micro RNeasy RNA isolation kits (Qiagen Germantown, MD). RNA quality was verified by microfluidics (Nano Labchip; Agilent Technologies, Palo Alto, CA), and concentration was determined spectrophotometrically (Nanodrop Technologies, Wilmington, DE). The sequences of primers to detect mRNA coding for ␣-, ␤-, and ␥-ENaC were as reported previously (3) with expected products of 159, 84, and 174 bases, respectively. Primers to detect 18S rRNA, which was used as an internal standard, also were as reported previously (62) . RT-PCR protocols were performed using One-step RT-PCR kits (Qiagen) and an automated thermocycler (Smart Cycler; Cepeid, Sunnyvale, CA). The PCR products were resolved by electrophoresis on a 1.5% agarose gel to verify a single band of expected mobility.
Western blot analysis. Cell lysates were made from MCF10A monolayers grown on permeable supports in the absence or presence of Ctx by using RIPA lysis buffer (1% Surfact-Amps NP-40; Pierce, Rockford, IL; 0.01% SDS in PBS) including a protease inhibitors (cOmplete Mini Protease Inibitor Cocktail; Roche Diagnostics, Indianapolis, IN). Monolayers were dislodged by scraping, and cells were broken apart by repeated aspiration through a 20-gauge needle. Suspensions were placed on ice for 15 min followed by centrifugation at 14,000 rpm for 15 min at 4°C. Supernatants were transferred to fresh tubes, and protein concentrations were determined (Micro BCA protein assay kit; Pierce). Proteins (20 g) were loaded in each well of a polyacrylamide 4 -20% gradient precast gel (Thermo Scientific, Waltham, MA) for electrophoresis in a Tris-HEPES-SDS running buffer (12.1 g/l Tris-base, 23.8 g/l HEPES, and 1 g/l SDS). Proteins were resolved at 150 V for 1 h or when clearly resolved protein standards (Bio-Rad Laboratories, Hercules, CA) could be observed. Proteins were transferred to a polyvinylidene fluoride microporous membrane (Millipore, Billerica, MA) in buffer (10% methanol, 25 mM Tris base, and 192 mM glycine) at 4°C using 55 V for 4 h. Membranes were blocked with 5% blotting grade milk (Blotto nonfat dry milk; Santa Cruz Biotechnology, Santa Cruz, CA) in PBS that included 0.1% Tween 20 at room temperature for 4 h or at 4°C overnight. Membranes were probed with anti-␣-ENaC (4 g/ml, Thermo Scientific no. PA1-920A, a rabbit polyclonal antibody raised against amino acids 20 -42 of rat ␣-ENaC), anti-␤-ENaC (6 g/ml, Santa Cruz Biotechnology no. SC-25354, a mouse monoclonal antibody raised against amino acids 271-460 of human ␤-ENaC), or anti-␥-ENaC (1 g/ml, Thermo Scientific no. PA1-922, a rabbit polyclonal antibody raised against amino acids 630 -649 of rat ␥-ENaC) antibodies. Secondary antibodies were goat-anti-rabbit (Thermo Scientific no. 31460) and goat-anti-mouse (both used at 40 ng/ml; Thermo Scientific no. 31430). PBS with Tween 20 was used as the washing buffer. Immunized membranes were visualized after being enhanced by chemiluminescence with West Femto Maximum Sensitivity substrate (Thermo Scientific). Nedd4-2 was detected (1: 500 dilution, Cell Signaling no. 4013, a rabbit polyclonal antibody raised against residues surrounding Glu 271 of human Nedd4-2; secondary goat-anti-rabbit at 40 ng/ml, Thermo Scientific no. 31460) using similar protocols. Occludin (0.5 g/ml, Invitrogen, Camarillo, CA, no. 71-1500, a rabbit polyclonal antibody), ␤-actin (1:1000 dilution, Sigma no. A2066, rabbit polyclonal antibody), and Na-KATPase ␣ 1-subunit (2 g/ml, Novus Biologicals, Littleton, CO, no. NB300-146, a mouse monoclonal antibody) were used in various experiments, as indicated, as internal standards for sample loading.
Cell surface biotinylation. Surface expression on MCF10A cells was assessed using biotinylation followed by Western blotting. MCF10A cells were cultured on permeable supports and exposed to vehicle, Ctx (100 ng/ml) for 24 h, or Ctx for 2 h before conducting the biotinylation assay was conducted (EZ-link Sulfo-NHS-LC-Biotin and NeutrAvidin Agarose resin; Thermo Scientific) (11) . The Ringer solution was adjusted to 300 mosmol/kgH 2O with D-mannitol and was used to wash cells and to dissolve biotin. MCF10A cells were incubated with either mucosal or serosal biotin (500 g/ml) in Ringer solution at 4°C for 30 min. After biotin incubation, cells was washed five times with glycine (50 mM) in Ringer solution. Cells were lysed in RIPA buffer with protease inhibitors (cOmplete Mini; Roche Diagnostics). Cell lysates were placed on ice for 15 min, disrupted by aspiration through a 20-gauge needle, and centrifuged at 14,000 rpm for 15 min at 4°C. Supernatant was collected and diluted with lysis buffer to achieve equal protein concentrations in all samples. Biotinlabeled proteins were separated using agarose resin with spin columns (Thermo Scientific) and suspended in Laemmli sample buffer containing DTT (50 mM) before electrophoretic resolution as described above.
Immunoprecipitation of ubiquitin. Whole cell lysates (WCL) were derived from MCF10A monolayers as described above. WCL were incubated with protein A/G PLUS-Agarose immunoprecipitation reagent (sc-2003; Santa Cruz Biotechnology) for 1 h at 4°C to remove proteins that bind to agarose nonspecifically. These samples were centrifuged at 2,500 rpm for 5 min at 4°C, and the supernatant was collected. Supernatant protein concentration was determined by the BCA protein assay kit, and all samples were adjusted with RIPA buffer to achieve equal concentrations. Equal volumes of protein samples were incubated with anti-ubiquitin antibody [concentration ratio: antibody:protein ϭ 1:1,000; goat polyclonal ubiquitin antibody (N-19), sc-6085, lot no. C2312; Santa Cruz Biotechnology] overnight at 4°C. Portions of the WCL were loaded along with the IP eluates, as indicated in the respective figures. The following day, protein A/G PLUS-agarose was added to each protein-antibody mix and allowed to incubate for 2 h at 4°C. Ubiquitinated proteins were separated using spin columns with paper filters (Thermo Scientific) and suspended in Laemmli sample buffer containing DTT (50 mM) before electrophoretic resolution as described above.
Data analysis. Statistical analysis was conducted using SigmaPlot (ver. 10.0; Systat Software, Chicago, IL) and Excel (ver. 14.0.6129.5000; Microsoft, Redmond, WA). Student's t-test for unpaired or paired data and ANOVA were used, as appropriate. Dunnett's test was used for post hoc analasis, when required. Summarized data are presented as means Ϯ SE. Treatment effects were considered significant when the probability of a type I error was Յ0.05.
RESULTS
Ctx elevates amiloride-and benzamil-sensitive I sc across MCF10A cells. MCF10A cells were cultured on permeable supports in the absence or presence of Ctx and mounted in modified Ussing-style flux chambers to test for electrogenic ion transport. Results presented in Fig. 1A show that these cells formed an electrically tight epithelial barrier that exhibited a positive I sc (4.89 or 11.54 A cm Ϫ2 , cultured for the final 24 h in the absence or presence of Ctx, respectively) indicative of net cation absorption or anion secretion. With the use of Ohms law, R te across each monolayer was calculated based on the current associated with a periodic 1-mV bipolar pulse. MCF10A cells cultured in typical medium exhibited greater R te (2,808 Ϯ 212 ⍀·cm 2 ) compared with cells exposed to Ctx for 1 day (731 Ϯ 77 ⍀·cm 2 ; n ϭ 4, paired). These data demonstrate that MCF10A cells generate a tight epithelial barrier in both culture conditions, although Ctx is associated with a greater conductivity. Additionally, cells cultured in the presence of Ctx exhibited greater basal I sc (12.04 Ϯ 0.38 A/cm
2 ) compared with their untreated counterparts (4.74 Ϯ 0.21 A/ cm 2 ; n ϭ 4, paired). Amiloride (10 M), which blocks ENaC, was added to the apical medium during the recording. Outcomes presented in Fig. 1A suggest that monolayers exposed to Ctx have greater amiloride-sensitive I sc , indicating enhanced Na ϩ absorption. Forskolin and bumentanide cause only modest changes in I sc . There was no detectable effect of Ctx on the response to either forskolin or bumentanide.
Experiments were conducted to determine the time course over which the effects of Ctx occur. MCF10A cells were exposed to Ctx for periods ranging from 2 h to 7 days. The magnitude of amiloride-sensitive current for cells cultured in typical medium was 1.53 Ϯ 0.11 A/cm 2 , which was less than that observed for any duration of Ctx exposure (Fig. 1B) . Amiloride-sensitive I sc was elevated significantly at the earliest time point tested (2 h). The Ctx-induced increment appeared to plateau at 4 h and remained at or above this level for at least 2 days of exposure, after which the amiloride-sensitive component declined.
Both basal and Ctx-associated I sc were reduced, concentration dependently, by amiloride and benzamil. Figure 2A in- cludes typical tracings in which MCF10A monolayers were cultured with or without Ctx for 1 day, mounted in Ussing chambers, and exposed to escalating concentrations of amiloride or benzamil. The magnitude of amiloride and benzamil-sensitive current change for each concentration was expressed in proportion to the maximal inhibition, and a Michaelis-Menton function was fitted to each data set (Fig.  2B ). The apparent K d s (K app ) for amiloride were 0.41 Ϯ 0.05 and 0.36 Ϯ 0.11 M in the presence and absence of Ctx, respectively. Similarly, the K app s for benzamil were 0.03 Ϯ 0.01 and 0.01 Ϯ 0.01 M in the same respective conditions. Thus amiloride and benzamil exhibited concentration-dependent inhibition profiles that are consistent with the block of ENaC channels; benzamil was 20 times more potent than amiloride (18, 59) . Additionally, 5-N-ethyl-N-isopropyl-amiloride (EIPA), an amiloride analog that preferentially inhibits the Na ϩ /H ϩ exchanger (NHE) at relatively low concentrations (e.g., Ͻ10 M) but affects ENaC only at very high concentrations (i.e., Ͼ100 M), was used. Even at the highest concentration employed (30 M), EIPA failed to affect the amiloride sensitive I sc (data not shown). Taken together, the results suggest that the Ctx-induced amiloride-sensitive I sc is ENaC-mediated Na ϩ transport.
In addition to amiloride, the effects of forskolin, bumetanide, and glibenclamide on ion transport across MCF10A monolayers were tested (see Fig. 1A ). Forskolin (2 M), an activator of adenylyl cyclase, elevated I sc modestly in both culture conditions. Bumetanide (20 M) , an inhibitor of Na ϩ -K ϩ -2Cl Ϫ cotransporter, and glibenclamide (300 M; data not shown), a cystic fibrosis transmembrane conductance regulator blocker at this concentration, caused a decline in I sc . Statistical analysis (n Ն 5) indicated that there was no detectable difference in the effects of forskolin, bumetanide, or glibenclamide between cells cultured in typical medium or in Ctx. Ctx B subunit fails to mimic effect of holotoxin. Cells were exposed to Ctx B subunit and outcomes were compared with cells exposed to the holotoxin. Typical and summarized data are presented in Fig. 3 . Amiloride-sensitive I sc was significantly greater only in the presence of the holotoxin. Ctx B subunit alone had no detectable effect on amiloride-sensitive I sc . After Ussing experiments were completed, protein was isolated from MCF10A cells and Ctx B subunit immunoreactivity was detected by Western blot in lysates of cells exposed to Ctx or Ctx B subunit. Similar labeling intensity for Ctx B subunit was observed in lysates derived from both treatments (Fig. 3C ). This outcome shows that Ctx B was internalized by the cells to a similar extent in the absence and presence of Ctx A. The results suggest that the Ctx A subunit or the holotoxin, the A subunit together with B subunits, is required to regulate ENaC activity in these mammary epithelial cells.
Ctx effects are not reversed by acute washout. MCF10A cells were exposed to vehicle or Ctx for 12 h and either were assessed immediately in Ussing chambers or the medium was replaced with Ctx-free medium and assays were conducted 12 h later (Fig. 4) . All monolayers that were exposed to Ctx exhibited greater spontaneous and amiloride-sensitive I sc . The magnitude of this I sc was not diminished by the 12-h washout period. Results presented in Fig. 1 show a slow onset for Ctx effects that approach or achieve maximal I sc only with Ͼ2h of exposure. Figure 4 demonstrates that the onset for the reversal of this effect requires Ͼ12 h as no detectable reversal was observed at this time.
Forskolin and isoproterenol do not mimic the effects of Ctx on amiloride-sensitive I sc . Ctx is best known to elevate intracellular cAMP in intestinal epithelial cells by activating adenylyl cyclase and ultimately causing massive secretory diarrhea. Thus other treatments that are thought to elevate cytosolic cAMP were evaluated. MCF10A cells were cultured in the presence or absence of Ctx or forskolin (300 nM) for 1 or 2 days before assessment. Amiloride-sensitive I sc was significantly greater only when cells were cultured in the presence of Ctx; forskolin induced no significant difference (Fig. 5) . Furthermore, typical results show that acute exposures to either forskolin (2 M) or Ctx (100 ng/ml) have little effect on amiloride-sensitive I sc . Similarly, isoproterenol, a ␤-adrenergic receptor agonist, was used to determine whether increasing cAMP following the activation of a G protein-coupled receptor could mimic the effect of Ctx on MCF10A cells (27) . Results presented in Fig. 6 show that MCF10A cells exposed in culture Fig. 4 . Ctx-enhanced amiloride-sensitive Isc was not reduced with washing out. A: typical data from MCF10A cells that were exposed to vehicle or Ctx for 12 h before assay or followed by culturing for 12 h in typical medium. B: data summarized from A and 6 similar experiments that included each of the 4 conditions. Ctx-enhanced amiloride-sensitive Isc was not reduced with washing out. to isoproterenol (100 nM) for 1 day had amiloride-sensitive I sc that was modestly greater, but the magnitude of I sc did not approach the level observed with Ctx.
To test further for a role of cAMP/PKA in the response, cells were concurrently exposed to isoproterenol, Ctx and/or R pcAMP, a cAMP antagonist. Results presented in Fig. 6 show first that R p -cAMP has no discernible effect on basal I sc but that the acute effect of isoproterenol was inhibited by Ͼ60%, as would be expected. Results presented in Fig. 6 further suggest that chronic (24 h) exposure to either Ctx or to isoproterenol elevates cAMP to the extent that acute exposure to isoproterenol is virtually without effect. Importantly, concurrent exposure to R p -cAMP did not abrogate the effect of Ctx on amiloride inhibitable I sc . In a separate set of experiments, the effect of H89 (10 M), a PKA inhibitor was evaluated. Results presented in Fig. 6D show that H-89 enhanced basal I sc modestly. More importantly, the increment in amiloride-sensitive I sc that is induced by Ctx was not inhibited by H-89. The results presented in Figs. 5 and 6, when taken together, suggest quite strongly that the Ctx-associated increment in amiloridesensitive I sc likely involves a cellular pathway(s) that is independent of cAMP/PKA.
Ctx elevates amiloride-sensitive I sc only in the presence of cortisol. Amiloride-sensitive I sc was present consistently in MCF10A monolayers and was significantly greater when cells were exposed to Ctx. The results suggest strongly that Ctx enhanced Na ϩ transport across MCF10A monolayers by increasing the expression and/or the activity of ENaC. To test these possibilities, MCF10A cells were cultured in the presence or absence of cortisol and/or Ctx. Amiloride-sensitive I sc was detected only when cells were cultured in the presence of the corticosteroid (Fig. 7) ; in the absence of cortisol, Ctx was without effect. The outcomes show that Ctx fails to induce amiloride-sensitive I sc . Rather, Ctx potentiates the magnitude of amiloride-sensitive I sc that is induced by cortisol. Consistent with earlier reports (3, 36) on epithelial cell culture in general, cortisol exposure was associated also with enhanced R te , which is shown by the larger I sc deflections associated with the periodic voltage steps in of Fig. 7 , right, when cortisol was absent.
Ctx has no effect on ENaC mRNA expression. RNA was isolated following exposure to cortisol and/or Ctx and semiquantitative RT-PCR was used to detect and quantify ␣-, ␤-, and ␥-ENaC transcripts. Threshold cycle (CT) value for each ENaC subunit was normalized to the CT for 18S, and ⌬⌬ CT was used to calculate copy number of transcripts in each condition relative to the basal medium, which contains cortisol. There is little indication that Ctx affected the number of transcripts coding for any ENaC subunit. A modest trend toward greater ␥-ENaC mRNA was detected, but the effect did not achieve statistical significance (P Ͼ 0.06). Consistent with previous observations in other mammary systems (36) , cortisol is associated with a doubling of mRNA coding for ␣-ENaC (i.e., a 50% reduction when cortisol is withdrawn) and greater than a 10-fold increase in the number of mRNA copies coding for either ␤-or ␥-ENaC (3, 36) . Ultimately, the results show that Ctx does not cause a detectable change in ENaC mRNA expression but that the effect of Ctx on amiloride-sensitive I sc was dependent on the induction of ENaC expression by corticosteroids.
Ctx has no effect on ␣-, ␤-, or ␥-ENaC immunoreactivity. Experiments were designed to determine whether Ctx could enhance ENaC expression at the protein level independent of an effect on mRNA expression. Three ENaC subunits were examined in lysates that were derived from MCF10A monolayers exposed to Ctx or to the vehicle in the final day of culture. Intensely labeled bands of expected mobility were present in each of the samples (Fig. 8) . Densitometric analysis showed that there were no detectable differences in band intensities for any of the ENaC subunits when normalized to occludin (65 kDa), Na-K-ATPase ␣ 1 (95 kDa), or ␤-actin (42 kDa, not shown) as an internal standard in each lane. The results show that Ctx-enhanced Na ϩ transport across MCF10A cells was not elicited by elevating the protein expression of any of the three ENaC subunits, which leaves the possibility that Ctx affects Na ϩ transport across MCF10A monolayers by changing ENaC localization or channel gating.
Ctx elevates the abundance of ␤-and ␥-ENaC at the apical cell surface. To evaluate the membrane localization of ENaC subunits, biotinylation assays were conducted in conjunction with Western blot analysis. MCF10A monolayers were exposed to Ctx or typical medium followed by biotin labeling for 30 min at 4°C. Western blots revealed ␤-ENaC and ␥-ENaC immunoreactivity in all samples. Importantly, results presented in Fig. 9 show that both ␤-ENaC and ␥-ENaC on the apical cell surface (AP) were elevated following exposure to Ctx for 2 h or 1 day. There were no detectable differences in the band densities on total protein expression (whole cell lysates) between vehicle and Ctx-treated cells (Veh_WCL vs. Ctx2h_WCL vs. Ctx1d_WCL). The double bands representing ␥-ENaC (Fig. 9B) , which were present in whole cell lysates, are consistent with both the full-length and the cleaved form of ␥-ENaC. The single band detected with biotinylation at the apical cell surface is consistent with the cleaved form of the protein, and it is elevated in Ctx-treated cells compared with vehicle. Occludin was used as internal control for loading of protein samples. Although Ctx exposure does not cause a detectable change in the expression of either mRNA coding for any ENaC subunit or of the actual ENaC subunits, these results indicate that Ctx causes a change in ENaC distribution such that there is an increase in the abundance of both ␤-and ␥-ENaC at the apical cell surface.
Effects of Ctx are not blocked by cytosolic pathway inhibitors.
Experiments were conducted to test whether Ctx affects ENaC protein trafficking from the endoplasmic reticulum to the Golgi. Figure 10A shows that amiloride-sensitive I sc across MCF10A cells was reduced by brefeldin A, a compound that disrupts cytosolic trafficking. In the presence of brefeldin A (10 mg/ml), amiloride-sensitive I sc was reduced by half, both with and without Ctx exposure. Brefeldin A clearly affects the expression or activity of ENaC at the apical cell membrane. However, the increment induced by Ctx exposure is not disproportionately affected by the trafficking disruptor. These results suggest that the effect of Ctx on ENaC distribution occurs at a postGolgi locale.
Phosphatidylinositol-3-kinase (PI3K) is a lipid kinase that can stimulate ENaC activity (2, 34, 39) . MCF10A cells were exposed to LY294002 (50 M), a PI3K inhibitor, in the presence or absence of Ctx. Like brefeldin A, LY294002 caused a reduction in amiloride-sensitive I sc both in the absence and in the presence of Ctx (Fig. 10B) . Regardless of whether LY294002 was present, the effect of Ctx was to increase amiloride-sensitive I sc by fivefold relative to the baseline conditions. While some portion of the activity or expression of ENaC is sensitive to LY294002, this outcome indicates that the effect of Ctx on ENaC is not mediated by the PI3K pathway.
Ctx increases Nedd4-2 expression. Nedd4-2, a cytosolic ubiquitin ligase, can induce ENaC retrieval from the cell membrane and subsequent degradation (4, 15, 37, 65) . Western blot analysis was conducted with lysates from MCF10A monolayers that had been exposed to Ctx or vehicle using primary antibodies that label both phosphorylated (inactive) and nonphosphorylated (active) Nedd4-2. Ctx appeared to increase the signal intensity for both the active nonphosphorylated (110 kDa) and the inactive phosphorylated (130 kDa) Nedd4-2 forms (Fig. 11) . Densitometric analysis showed that Ctx exposure was associated with a statistically significant increase in the relative density of the 130-kDa bands following Ctx exposure. This result suggests that Ctx increases Nedd4-2 expression, but more importantly that Ctx exhibits a more obvious effect to increase the amount of the phosphorylated form, which would be expected to reduce the relative activity of Nedd4-2 and thus reduce retrieval of ENaC from the cell membrane.
Ctx increases the monoubiquitination of ␤-and ␥-ENaC. To test whether Ctx alters ENaC ubiquitination, immunoprecipitation of ubiquitin was conducted using whole cell lysates from MCF10A monolayers and was followed by Western blot analysis. ␤-and ␥-ENaC subunits were detected by Western blot in the ubiquitin immunoprecipitates (Fig. 12) . Importantly, the results show that the most prominent form of either subunit in the immunoprecipitate is monoubiquitinated. Even with extended exposure times, polyubiquitinated forms of ENaC were not readily detected. It is obvious with the raw data shown and densitometric analysis indicates that Ctx increased ␤-and ␥-ENaC ubiquitination by approximately fourfold (4.27 Ϯ 2.01 and 3.60 Ϯ 1.45; n ϭ 4; respectively). This result suggests that Ctx increases monoubiquitination of ENaC that may associated with surface retention (65) .
DISCUSSION
This line of investigation demonstrates that epithelial cells derived from the human mammary gland, MCF10A cells, express ENaC and that Ctx elevates Na ϩ absorption by increasing the abundance of ENaC in the apical membranes of these epithelial cells. That Ctx regulates Na ϩ absorption across human mammary epithelium is a novel observation. The re- Fig. 8 . Ctx has no effect on ␣-, ␤-, or ␥ -ENaC expression. Representative Western blot of MCF10A cells that were exposed to Ctx or vehicle for 24 h. Western blot analysis of whole cell lysates was conducted using primary antibodies raised against human ␣-, ␤-, or ␥-ENaC, as indicated. Membranes were subsequently stripped and reprobed with antibodies to Na-K-ATPase ␣1 or occludin, as indicated, to verify equal protein loading. Arrows indicate bands of expected mobility. Results are representative from at least four experiments for each target protein.
sults demonstrate that Ctx-treated MCF10A cells exhibit greater basal ion flux and greater amiloride-sensitive ion transport indicating enhanced Na ϩ absorption. However, the outcomes show that the link between Ctx and Na ϩ absorption is independent of cAMP and seems not to be affected by brefeldin A. Ctx has no effect on the expression of mRNA coding for ␣-, ␤-, or ␥-ENaC subunits. Furthermore, there were no detectable effects on protein expression of any of ENaC subunits when assessed by Western blot. Rather, the results show that Ctx changes the distribution of ENaC between cytosolic and apical pools. Ctx increases Nedd4-2 expression and the apparent ratio between the phosphorylated (inactive) and nonphosphorylated (inactive) forms. The greater overall amount of Nedd4-2 and the relatively greater amount of inactive Nedd4-2 may account for the elevated level of monoubiquitinated but not polyubiquitinated ENaC subunits, which would be expected to reduce protein retrieval from the apical membrane and, subsequently, protein degradation. The underlying mechanism(s), however, remains to be defined further; in addition to reduced retrieval there could be greater insertion or potentially greater recycling of the channels back to the apical membrane.
Regardless, the results demonstrate that corticosteroids substantially upregulate the expression of mRNA coding for ENaC subunits and that corticosteroids are required for amiloridesensitive transport to be detected. The results demonstrate that Ctx enhances Na ϩ absorption by elevating the proportion of ENaC in the apical membrane of these mammary epithelial cells. A working model of human mammary epithelia to account for the low Na ϩ concentration that is observed in human milk is depicted in Fig. 13 . In this model, cortisol binds to glucocorticoid receptors and regulates ENaC mRNA expression (36) . In mammary epithelia, cortisol increases mRNA coding for the expression of all three ENaC subunits (3, 36) , but the cortisolinduced increment differs for each subunit. ␤-and ␥-ENaC mRNA increased Ͼ10-fold and ␣-ENaC increased ϳ2-fold (36). Upon translation, newly synthesized ENaC subunits assemble to form a heterotrimeric channel while processing through the endoplasmic reticulum (52) . ENaC exits the endoplasmic reticulum and enters the Golgi apparatus where it can be activated by furin, which cleaves the extracellular loops of ␣-and ␥-ENaC (13, 52) . ENaC channels are trafficked to the apical membrane where they allow Na ϩ to enter the cell by moving down its electrochemical gradient, which, in conjunction with Na ϩ -K ϩ -ATPase at the basolateral membrane, can account for net Na ϩ transport from the apical luminal compartment to the interstitial compartment (i.e., net absorption). Nedd4-2 can bind to surface ENaC to promote retrieval via endocytosis (51) . All three ENaC subunits contain a PY (PPXY) motif that can interact with Nedd4-2 WW domains (52). Since Nedd4-2 is an E3 ubiquitin ligase, the interaction with Nedd4-2 results typically in ENaC Fig. 9 . Ctx elevated the abundance of ␤-and ␥-ENaC at the apical cell surface. MCF10A cells were exposed to Ctx for 2 h or 1 day. Biotinylation followed by Western blot analysis was used to detect surface expression of ␤-ENaC (A) and ␥-ENaC (B). Densitometric analysis showed that Ctx exposure was associated with increased intensities of bands that had been biotin labeled. Occludin labeling is used as an internal standard for protein loading. Results are representative from at least 3 observations in each condition. The protein was loaded as the following sequence: vehicle with apical biotinylation (Veh_AP), vehicle whole cell lysates (Veh_WCL), Ctx 2 h with apical biotinylation (Ctx2h_AP), Ctx 2-h whole cell lysates (Ctx2h_WCL), Ctx 1 day with apical biotinylation (Ctx1d_AP), and Ctx 1-day whole cell lysates (Ctx1d_WCL).
ubiquitination and ultimately to degradation via the proteasome pathway (41) . Phosphorylation of Nedd4-2 prevents the interaction with ENaC. In this article, we show that Ctx elevates amiloride-sensitive I sc by increasing the numbers of ENaC channels in the apical membrane and we provide evidence to suggest that the activity of Nedd4-2 is likely reduced by phosphorylation following Ctx exposure.
The structure of Ctx and its pathophysiological effects on intestinal epithelia have been well characterized (43, 45, 46) . Ctx is secreted by the Gram-negative bacterium Vibrio cholera and is responsible for massive secretory diarrhea in cholera disease. The heat labile toxin of Escherichia coli, which also causes secretory diarrhea, is virtually identical in both structure and pathological mechanism (43) . Ctx belongs in the AB5 toxin structure family, which is defined by one A subunit and five B subunits (43, 55) . Ctx binds to GM1 by Ctx B subunits and is internalized via lipid rafts or by endocytosis (20) . The binding site for Ctx, the ganglioside GM1, is reportedly present in the mammary gland (14) . After internalization, as Fig. 13 shows, the toxin is transported in a retrograde fashion from the apical membrane to the Golgi apparatus and then to the endoplasmic reticulum. Once in the endoplasmic reticulum lumen, the A subunit becomes dissociated from the B subunits and retro-translocates to the cytosol. In the cytosol, the Ctx A subunit catalyzes the ADP-ribosylation of G s ␣ to activate the G protein irreversibly and to increase the cytosolic cAMP level, which activates PKA and ultimately induces Cl Ϫ secretion (20) . The well-characterized effects of Ctx are through the cAMP/PKA-dependent pathway. Ctx also has effects on A6 cells derived from Xenopus laevis distal nephron where it had been reported that Ctx increases the number of ENaC channels in the apical membrane by a cAMP-dependent mechanism but without detectable effects on the open probability of the channel (24) . In PC-12 cells, Ctx also reportedly stimulates adenylyl cyclase to increase cAMP levels (50) . In these cells, Ctx increased lactate production, an indicator of increased metabolic rate, and the effect was inhibited by H-89 (50) . The current results suggest that Ctx increases phosphorylation of Nedd4-2 (Fig. 11) , which prevents the interaction between Nedd4-2 and surface ENaC, ultimately reducing the rate of internalization. Various pathways can modulate Nedd4-2 phosphorylation, such as glucocorticoid-induced kinase (SGK) and PKA. Indeed, the current results suggest strongly that Ctx increases cAMP accumulation in these cells. However, our reported outcomes suggest that Ctx regulates Na ϩ transport via a mechanism that is independent of cAMP/PKA. Inhibition of PKA by H-89 or by Rp-cAMP had no effect on Ctx increased amiloride-sensitive I sc . The underlying mechanism(s) that contribute to Ctx-associated Nedd4-2 phosphorylation remains to be determined.
Numerous studies have focused on Na ϩ transport through ENaC in the mammary gland, but this study is the first to demonstrate that Ctx modulates Na ϩ transport through ENaC across human mammary epithelium. Four decades ago, and again more recently, a mammary epithelial model based on in vivo observations with goats was proposed in which the apical membrane was freely permeable to cations but not to anions (22, 48) . In this model, cationic composition of milk was set by activity of the Na ϩ -K ϩ -ATPase at the basolateral membrane (22) . An overwhelming amount of more recent evidence demonstrates that ENaC is present in the apical membranes of mammary epithelial cells, that the expression of ENaC in these membranes is regulated, and it is postulated that ENaC activity contributes to milk composition for a number of species (1, 3, 
19, 35
). The present study extends observations reported for bovine mammary epithelium, which showed both cation absorption and anion secretion (36, 44) . The current results provide strong evidence that ENaC is expressed in MCF10A cells, which are of human origin, and contributes to regulated Na ϩ transport. An important question for this study is to determine whether Ctx increases ENaC activity by targeting the cAMP/PKA pathway. There is no doubt that Ctx can elevate cAMP level in MCF10A cells (27) . Indeed, a limited number of our own observations show that Ctx is associated with elevated cAMP generation in MCF10A cells (data not shown). The duration to the effect of Ctx on elevation of amiloride-sensitive I sc is consistent with the expected time course for activation of adenylyl cyclase activity (45, 46) and for the induction of intestinal anion secretion as we showed previously (31) . Thus studies were designed to test whether forskolin, which activates adenylyl cyclase to increase cytosolic cAMP, can mimic the Ctx-induced effect by activation of the cAMP/PKA pathway. In a recent study, MCF10A cells were cultured in the presence of forskolin and showed increased intracellular cAMP level (58) . The current results, however, show that forskolin did not mimic Ctx. Likewise, isoproterenol, a ␤-adrenergic receptor agonist, failed to mimic the Ctx effect. Both treatments elevated cAMP generation (data not shown), and both substantially reduced an acute effect of isoproterenol on I sc (e.g., see Fig. 6 ). To test further whether Ctx induces Na ϩ absorption by activating PKA, a small array of selective inhibitors with different mechanisms of actions (H89, R pcAMP, and KT5720) was employed in conjunction with Ctx. H89 does not reduce Ctx-potentiated amiloride-sensitive I sc . Similarly, R p -cAMP, a competitive antagonist of the cAMP activation site on PKA, did not inhibit Ctx-induced amiloridesensitive I sc but did abolish the acute increase in I sc induced by isoproterenol (26, 61) . KT5720 reportedly has a similar mechanism as H89 to inhibit PKA activity (16, 26) . In our study, KT5720 did not reduce Ctx-potentiated amiloride-sensitive I sc but inhibited the acute effect of isoproterenol (data not shown). Together, the results suggest that Ctx-induced Na ϩ absorption across MCF10A cells is not dependent on the PKA pathway. Somewhat surprisingly, H-89 increased amiloride-sensitive I sc in cells exposed only to vehicle, which could reflect an increase in channel open probability as has been reported in fetal rat alveolar type II epithelium (25) . Furthermore, to verify that H89 is working by inhibiting PKA, PVD9902 cells (5) were exposed to H89 for 24 h in a parallel experiment and the response to both 8-cpt-cAMP and forskolin was reduced, validating the effectiveness of H89 in the reported assays.
To investigate further the intracellular pathway(s) that Ctx may target, the endoplasmic reticulum-associated degradation (ERAD) pathway was evaluated. Ctx and specifically its B chain were shown to increase expression of the ERAD proteins Bip, Derlin-1, and Derlin-2 (7). However, in the present study, the Ctx B subunit alone did not mimic the holotoxin effect. Moreover, Western blot analysis showed that Bip expression was not changed (data not shown). Due to the specific process by which Ctx accesses cells, the B subunit must bind to the cell membrane receptor to facilitate entry of the A subunit. There- Fig. 12 . Ctx elevated ␤-and ␥-ENaC monoubiquitination. A: ubiquitinated ␤-ENaC was detected by immunoprecipitation of ubiquitin and followed by Western blot of lysates from MCF10A monolayers exposed to either vehicle or Ctx for 1 day using antibodies raised against ␤-ENaC. B: ubiquitinated ␥-ENaC was detected similarly. C: increasing membrane exposure time from 20 s (B) to 60 s, the Ctx-induced increment of the signal of ␥-ENaC pulled down by immunoprecipitation of ubiquitin is more evident. D: densitometric analysis showed Ctx increased ␤-and ␥-ENaC monoubiquitination although only the effect of Ctx on ␥-ENaC reached statistical significance. Densities were expressed relative to the intensity of whole cell lysates and are summarized from 4 paired samples.
fore, an effect of the A subunit alone is unlikely in this cell culture system. The amiloride-sensitive I sc was maximized after 24 h exposure to Ctx and declined after 2 days. Although amiloride-sensitive I sc decreased with prolonged exposure to Ctx, the I sc remained elevated by Ctx at all time points. The underlying mechanism(s) to account for the decline in amiloride-sensitive current after 4 days exposure to Ctx requires further investigation. The half-life of ENaC on the cell surface is reported to be from a few minutes to 8 h or more, but the functional channel is present for ϳ3.5 h (32, 63). The current results show greater ENaC residency in the apical membrane, which could reflect increased insertion, decreased retrieval, or increased recycling. Additional studies are required to determine whether Ctx increases half-life of ENaC on the cell membrane, although the results suggest that this is the case. Nedd4-2 is a widely studied E3 ubiquitin-protein ligase and critical for ENaC retrieval from the cell surface and ultimately for protein degradation (40, 51, 53) . It has been reported that cAMP can inhibit Nedd4-2 activity by enhancing phosphorylation (53) . In this study, we observed that Ctx increases phosphorylation of Nedd4-2, but inhibition of PKA has no effect on amiloride-sensitive I sc . Whether Ctx-associated phosphorylation of Nedd4-2 is due to targeting the cAMP/ PKA pathway or other novel mechanisms requires further study. It has been well documented that ubiquitination can regulate ENaC degradation by Nedd4-2-mediated mechanisms (23, 57, 65) . There are two types of ubiquitination based on how many ubiquitin moities attach to lysine residues on substrate proteins, monoubiquitination and polyubiquitination (38, 42) . Monoubiquitination was suggested to regulate protein nondegradative activities, such as DNA repair, histone function regulation, and gene expression (38, 42) . Polyubiquitination appears to target proteins for degradation in the 26S proteasomes complex (12, 42) . It had been shown that ENaC degradation can be regulated by mono-and polyubiquitination both in transfected cells (57, 65) and in cells expressing ENaC under native regulation (23) . Our data show that ␤-and ␥-ENaC are monoubiquitinated in MCF10A cells and Ctx increases ENaC monoubiquitination. However, we did not detect any polyubiquitinated ENaC in this study. Monoubiquitination of ␤-ENaC was associated elevated surface ␤-ENaC expression in HEK 293T cells that were transfected with mutated ubiquitin to prevent formation of polyubiquitin chains (65) . Some reports suggest that different types of E3 ubiquitinprotein ligase or E2 ubiquitin conjugating enzyme alone can regulate protein monoubiquitination (38, 42) . Our data suggest that Ctx increases ENaC surface expressions and decreases Nedd4-2 activities. It is possible that Ctx elevates endogenous ENaC monoubiquitination by novel mechanisms independent of an effect on Nedd4-2.
This study has implications for the pathology and treatment of mastitis. Mastitis has great impact on both human society and the dairy industry. Approximately 10% of lactating women suffer from mastitis (9) . This disease is extremely painful, it influences breast milk quality and volume, and the interruption of normal breastfeeding can weaken social bonding (56) . In the dairy industry, mastitis has significant effects on milk production and is the greatest financial burden of any animal disease in U.S. agriculture (49) . The pathophysiology remains poorly understood. Elevated milk electrical conductivity and elevated electrolytes have been used to indicate the preclinical stages of mastitis (21) . Loss of the mammary epithelial barrier is documented in mastitis (35, 64) . There are ongoing questions whether mastitis compromises the epithelia barrier to induce an increase in milk electrolytes or whether mastitis induces a decrease in the activity of Na ϩ absorption mechanisms to increase milk electrolytes, which causes the epithelia barrier to break down. Using an in vitro system employing bovine mammary epithelial cells, we showed previously that changes in Na ϩ concentration on the apical (i.e., milk) side of the cells had rapid and profound impact on the epithelial barrier (35) . A reduction in the apical Na ϩ concentration led to an increase epithelial electrical resistance, indicating a tight epithelial barrier. Our outcomes suggest that ENaC-mediated Na ϩ absorption across mammary epithelium, which is regulated by corticosteroids, can contribute to the generation and maintenance of the epithelial barrier (36) . Conversely, the results suggested Fig. 13 . Mammary cell model to account for monovalent ion transport and especially for Ctx enhanced Na ϩ absorption. In this model, cortisol binds to glucocorticoid receptor and induces (␤ and ␥) or enhances (␣) the expression of mRNA coding for ENaC subunits, which are transcribed in the endoplasmic reticulum, processed through the Golgi apparatus and trafficked to the apical membrane. Under normal conditions, Nedd4-2 binds to ENaC in the apical membrane to induce its retrieval and, upon ubiquitination, its degradation. Ctx elevates amiloride-sensitive Isc by increasing the number of ENaC channels in the apical membrane. As depicted, Ctx is composed of 1 A subunit and 5 B subunits and binds to GM1 by Ctx B subunits to internalize into cells. After internalization, Ctx is transported in a retrograde fashion from the apical membrane to the Golgi apparatus and then to the endoplasmic reticulum where the A subunit becomes dissociated from the B subunits and translocates to the cytosol. In the cytosol, the Ctx A subunit catalyzes the ADP-ribosylation of Gs␣ to irreversibly activate the G protein and increase cAMP level that activates PKA. However, the effect of Ctx on increased amiloride-sensitive Isc is independent of the cAMP/PKA pathway. Ctx increases phosphorylation of Nedd4-2, which would decrease its ability to promote retrieval of ENaC from the apical membrane, although the underlying mechanism is not defined. Ctx elevates monoubiquitination of ENaC, which may lead to more surface ENaC expression. Solid lines represent pathways that have been defined, and short dash lines represent predicted pathways. ␣, ␤, and ␥ represent ENaC mRNAs. GR, glucocorticoid receptor; CFTR, a cystic fibrosis transmembrane conductance; AC, of adenylyl cyclase.
that a reduction in ENaC activity might contribute to mastitis disease progression. The ultimate goal for this study is to identify key intermediates by which Ctx modulates ENaCmediated Na ϩ absorption. Further elucidation of this novel pathway will identify components of the cellular systems that can be targeted to circumvent or treat this costly disease. If these signaling mechanisms are present in epithelia at other locations throughout the body, one can envision new treatments being developed potentially to target hypertension, congestive heart failure, obstructive pulmonary disease, and other diseases of Na ϩ and fluid balance. In summary, our research suggests that Ctx elevates Na ϩ absorption across human mammary epithelia by increasing the abundance of ENaC in the apical membrane. The underlying mechanism is not fully defined but likely includes phosphorylation of Nedd4-2 and it appears to be independent of the cAMP/PKA pathway. These reported outcomes constitute a novel mechanism for the regulation of net Na ϩ transport that will likely have implications for epithelia throughout the body.
